Medicana Highlights Robotic Prostate Surgery as 2026 Review Reports Recovery Benefits, tell me about this news in (https://www.manilatimes.net/2026/10/01/tmt-newswire/globenewswire/medicana-highlights-robotic-prostate-surgery-as-2026-review-reports-recovery-benefits/2437114)
01-10-2026
The article covers an announcement by Medicana Health Group regarding the recovery benefits of robot-assisted surgery for prostate cancer, based on a 2026 research review.
Key Findings and HighlightsResearch Backing: The report references a systematic review published in International Urology and Nephrology, which evaluated 27 studies covering 38,530 patients.
Recovery Advantages: Robot-assisted radical prostatectomy demonstrated lower rates of blood transfusion and an average reduction in hospital stay of roughly 1.4 days compared to traditional open surgery.
Surgical Mechanism: The procedure involves removing the prostate and seminal vesicles through tiny abdominal incisions. The surgeon directly controls the instruments from an operating console using magnified 3D visualization to maneuver around delicate nerve and tissue structures; the robotic system does not operate autonomously.
Patient Selection and Expectations: Prof. Melih Balcı, MD, a urologist at Medicana Ataköy Hospital, emphasized that surgery is not mandatory for every patient. Treatment decisions rely on factors such as cancer stage, risk stratification, PSA levels, biopsy results, overall health, and life expectancy. Low-risk cases may use active surveillance instead.
Post-Operative Considerations: While nerve-sparing techniques are applied when oncologically viable, urinary continence and erectile function outcomes differ depending on age, baseline function, and tumor anatomy. Temporary urinary catheter use, incontinence, and erectile dysfunction remain possible risks that require pre-treatment consultation.
Study Limitations: The authors of the cited review noted that most included studies were non-randomized with varying outcomes, emphasizing the need for further randomized clinical trials with longer follow-up periods.